Comentario editorial
Quimioterapia neoadyuvante con gemcitabina-cisplatino vs. metotrexato-vinblastina-adriamicina-cisplatino en pacientes con carcinoma urotelial vesical llevados a cistectomía radical: metaanálisis
Neoadjuvant chemotherapy with gemcitabine-cisplatin vs. methotrexate-vinblastine-adriamycin-cisplatin in bladder urothelial carcinoma patients with radical cystectomy: Meta-analysis
Leído
4398
Vecesse ha leído el artículo
1032
Total PDF
3366
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 11 | 9 | 20 |
| 2025 11 | 32 | 18 | 50 |
| 2025 10 | 35 | 7 | 42 |
| 2025 9 | 22 | 19 | 41 |
| 2025 8 | 32 | 8 | 40 |
| 2025 7 | 48 | 9 | 57 |
| 2025 6 | 30 | 3 | 33 |
| 2025 5 | 35 | 4 | 39 |
| 2025 4 | 35 | 6 | 41 |
| 2025 3 | 34 | 5 | 39 |
| 2025 2 | 29 | 1 | 30 |
| 2025 1 | 52 | 2 | 54 |
| 2024 12 | 28 | 3 | 31 |
| 2024 11 | 71 | 5 | 76 |
| 2024 10 | 28 | 3 | 31 |
| 2024 9 | 35 | 4 | 39 |
| 2024 8 | 41 | 5 | 46 |
| 2024 7 | 48 | 1 | 49 |
| 2024 6 | 36 | 4 | 40 |
| 2024 5 | 81 | 5 | 86 |
| 2024 4 | 40 | 5 | 45 |
| 2024 3 | 44 | 2 | 46 |
| 2024 2 | 58 | 5 | 63 |
| 2024 1 | 56 | 4 | 60 |
| 2023 12 | 32 | 3 | 35 |
| 2023 11 | 45 | 13 | 58 |
| 2023 10 | 60 | 19 | 79 |
| 2023 9 | 45 | 6 | 51 |
| 2023 8 | 47 | 4 | 51 |
| 2023 7 | 50 | 4 | 54 |
| 2023 6 | 50 | 7 | 57 |
| 2023 5 | 40 | 9 | 49 |
| 2023 4 | 44 | 1 | 45 |
| 2023 3 | 26 | 4 | 30 |
| 2023 2 | 31 | 6 | 37 |
| 2022 1 | 20 | 5 | 25 |
| 2022 12 | 32 | 9 | 41 |
| 2022 11 | 41 | 10 | 51 |
| 2022 10 | 28 | 8 | 36 |
| 2022 9 | 28 | 13 | 41 |
| 2022 8 | 17 | 11 | 28 |
| 2022 7 | 23 | 6 | 29 |
| 2022 6 | 20 | 7 | 27 |
| 2022 5 | 23 | 9 | 32 |
| 2022 4 | 25 | 10 | 35 |
| 2022 3 | 50 | 4 | 54 |
| 2022 2 | 57 | 9 | 66 |
| 2021 1 | 44 | 4 | 48 |
| 2021 12 | 53 | 11 | 64 |
| 2021 11 | 44 | 6 | 50 |
| 2021 10 | 30 | 9 | 39 |
| 2021 9 | 20 | 13 | 33 |
| 2021 8 | 19 | 6 | 25 |
| 2021 7 | 22 | 6 | 28 |
| 2021 6 | 11 | 7 | 18 |
| 2021 5 | 20 | 4 | 24 |
| 2021 4 | 39 | 16 | 55 |
| 2021 3 | 13 | 8 | 21 |
| 2021 2 | 8 | 10 | 18 |
| 2020 1 | 8 | 9 | 17 |
| 2020 12 | 13 | 4 | 17 |
| 2020 11 | 12 | 12 | 24 |
| 2020 10 | 7 | 5 | 12 |
| 2020 9 | 17 | 11 | 28 |
| 2020 8 | 9 | 4 | 13 |
| 2020 7 | 9 | 8 | 17 |
| 2020 6 | 11 | 6 | 17 |
| 2020 5 | 15 | 9 | 24 |
| 2020 4 | 19 | 6 | 25 |
| 2020 3 | 18 | 5 | 23 |
| 2020 2 | 17 | 4 | 21 |
| 2020 1 | 18 | 4 | 22 |
| 2019 12 | 11 | 7 | 18 |
| 2019 11 | 8 | 0 | 8 |
| 2019 10 | 7 | 6 | 13 |
| 2019 9 | 12 | 4 | 16 |
| 2019 8 | 4 | 6 | 10 |
| 2019 7 | 18 | 7 | 25 |
| 2019 6 | 25 | 6 | 31 |
| 2019 5 | 56 | 13 | 69 |
| 2019 4 | 24 | 19 | 43 |
| 2019 3 | 3 | 5 | 8 |
| 2019 2 | 5 | 9 | 14 |
| 2019 1 | 4 | 7 | 11 |
| 2018 12 | 6 | 5 | 11 |
| 2018 11 | 6 | 13 | 19 |
| 2018 10 | 8 | 8 | 16 |
| 2018 9 | 4 | 3 | 7 |
| 2018 8 | 1 | 5 | 6 |
| 2018 7 | 4 | 14 | 18 |
| 2018 6 | 1 | 2 | 3 |
| 2018 5 | 6 | 13 | 19 |
| 2018 4 | 3 | 1 | 4 |
| 2018 3 | 4 | 2 | 6 |
| 2018 2 | 5 | 0 | 5 |
| 2018 1 | 3 | 2 | 5 |
| 2017 12 | 3 | 0 | 3 |
| 2017 11 | 3 | 3 | 6 |
| 2017 10 | 5 | 1 | 6 |
| 2017 9 | 4 | 3 | 7 |
| 2017 8 | 7 | 1 | 8 |
| 2017 7 | 7 | 1 | 8 |
| 2017 6 | 5 | 1 | 6 |
| 2017 5 | 8 | 4 | 12 |
| 2017 4 | 13 | 0 | 13 |
| 2017 3 | 21 | 23 | 44 |
| 2017 2 | 15 | 3 | 18 |
| 2016 1 | 13 | 1 | 14 |
| 2016 12 | 18 | 4 | 22 |
| 2016 11 | 27 | 2 | 29 |
| 2016 10 | 24 | 6 | 30 |
| 2016 9 | 27 | 7 | 34 |
| 2016 8 | 21 | 3 | 24 |
| 2016 7 | 34 | 5 | 39 |
| 2016 6 | 59 | 33 | 92 |
| 2016 5 | 48 | 27 | 75 |
| 2016 4 | 53 | 38 | 91 |
| 2016 3 | 70 | 28 | 98 |
| 2016 2 | 71 | 39 | 110 |
| 2015 1 | 60 | 33 | 93 |
| 2015 12 | 50 | 34 | 84 |
| 2015 11 | 36 | 14 | 50 |
| 2015 10 | 49 | 26 | 75 |
| 2015 9 | 56 | 12 | 68 |
| 2015 8 | 40 | 22 | 62 |
Mostrar todo